获得性或遗传性高凝状态患者的识别与管理进展
Update on recognition and management of patients with acquired or inherited hypercoagulability.
作者信息
Alving B
机构信息
Hematology/Medical Oncology Section, Washington Hospital Center, Washington, D.C. 20010, USA.
出版信息
Compr Ther. 1998 Jun-Jul;24(6-7):302-9.
PMID:9669094
Abstract
As many as 20% of individuals who develop venous thromboembolism (VTE) in an outpatient setting may have a mutation in factor V (factor V Leiden) or the prothrombin gene. Through testing for the inherited and acquired conditions for VTE, the clinician can develop strategies to prevent recurrences.
摘要
在门诊环境中发生静脉血栓栓塞（VTE）的个体中，多达20%可能存在凝血因子V（凝血因子V莱顿突变）或凝血酶原基因的突变。通过检测VTE的遗传性和获得性情况，临床医生可以制定预防复发的策略。
Zotero 插件